Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 61.50%
March 31, 2026 37.89%
December 31, 2025 9.66%
September 30, 2025 -31.73%
June 30, 2025 -63.58%
March 31, 2025 -18.16%
December 31, 2024 30.07%
September 30, 2024 32.17%
June 30, 2024 26.54%
March 31, 2024 6.40%
December 31, 2023 1.00%
September 30, 2023 14.45%
June 30, 2023 -0.79%
March 31, 2023 15.40%
December 31, 2022 59.35%
September 30, 2022 13.38%
June 30, 2022 -12.08%
March 31, 2022 -116.3%
December 31, 2021 -95.15%
September 30, 2021 -48.95%
June 30, 2021 -116.5%
March 31, 2021 -100.3%
December 31, 2020 -92.24%
September 30, 2020 -171.2%
June 30, 2020 20.10%
Date Value
March 31, 2020 19.81%
December 31, 2019 25.79%
September 30, 2019 12.72%
June 30, 2019 20.36%
March 31, 2019 18.56%
December 31, 2018 41.05%
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017 77.49%
March 31, 2017 74.86%
December 31, 2016 75.85%
September 30, 2016 77.35%
June 30, 2016 74.72%
March 31, 2016 78.60%
December 31, 2015 66.14%
September 30, 2015 66.08%
June 30, 2015 71.49%
March 31, 2015 67.91%
December 31, 2014 47.21%
September 30, 2014 67.67%
June 30, 2014 72.53%
March 31, 2014 71.47%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
ClearPoint Neuro, Inc. 59.79%
Abbott Laboratories 57.05%
AngioDynamics, Inc. 56.00%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%

Gross Profit Margin (Quarterly) Related Metrics